Comparison of Different Treatment Outcomes for Refractory Overactive Bladder: A Systematic Review and Meta-Analysis.

Toxins (Basel) · 2025 · PMC12568059 · PMID 41150180

Europe PMC DOI

hedged sentence

0.1100

closest p · 2.2× alpha

0.1100

boldest claim

The sentences

did not reach statistical significancep = 0.11not close (p > 0.1)

13.68%) experienced dramatic symptom improvement (≥75% reduction in urinary incontinence (UI) episodes, OR 4.40, 95% CI (2.64, 7.33); p < 0.00001; Figure 2 A) with BoNT-A, while more modest reductions (≥50%) in UI episodes did not reach statistical significance compared to placebo (55.84% vs. 33.42%; OR 2.37, 95% CI (0.82, 6.87); p = 0.11; Figure 3 A).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.